Overview
Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects
Status:
Completed
Completed
Trial end date:
2012-09-01
2012-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to assess the safety, tolerability, and affect on blood levels of miravirsen and telaprevir when administered together.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Santaris Pharma A/S
Criteria
Inclusion Criteria:- Healthy volunteers
- Weight ≤ 85 kg
- Females of non-childbearing potential (postmenopausal or surgically sterile) or males
who are surgically sterile or using an acceptable form of birth control
Exclusion Criteria:
- Current, clinically significant illness or medical condition